Abstract
Cell membrane-disrupting toxins (cytolysins) have great appeal as candidates for targeting to tumor cells by means of monoclonal antibodies, yet their use has been explored in only a few studies to date. Here, we appraise the potential of antibody-cytolysin conjugates, or ‘immunolysins’ for cancer therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alouf, J. E., 1976, Cell membranes and cytolytic bacterial toxins, in: “The Specificity and Action of Animal, Bacterial and Plant Toxins, Receptors and Recognition,” Series B, Vol. 1, P. Cuatrecasas, ed., Chapman and Hall, London.
Alouf, J. E., 1980, Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmac.Ther. 11:661.
Arbuthnott, J. P., 1982, Bacterial cytolysins (membrane-damaging toxins), in: Molecular Action of Toxins and Viruses, P. Cohen, and S. van Heyningen, eds., Elsevier Biomedical Press, Holland.
Bernheimer, A. W., and Rudy, B., 1986, Interactions between membranes and cytolytic peptides, Biochim.Biophys.Acta., 864:123.
Bhakdi, S., and Tranum-Jensen, J., 1985, Complement activation and attack on autologous cell membranes induced by streptolysin O. Infec.Immun., 48:713.
Bhakdi, S., and Tranum-Jensen, J., 1986, Membrane damage by channel-forming proteins: Staphylococcal α-toxin, streprolysin O and the C5b-9) complement complex, Biochem.Soc.Symp. 50.
Ellar, D. J., Thomas, W. E., Knowles, B. H., Ward, S., Todd, J., Drobnieswski, F., Lewis, J., Sawyer, T., Last, D., and Nichols, C., 1985, Biochemistry, genetics, and mode of action of Bacillus thuringiensis δ-endotoxins, in: Molecular Biology of Microbiol Dif-ferentation, J. A. Hoch and P. Setlow, eds., American Society for Microbiology, Washington DC, pp. 230–240.
Flickinger, R. A., and Trost, S. R., 1976, Cytotoxicity of antibody-phospholipase C conjugates on cultured Friend leukemia cells, Eur.J.Cancer 12:159.
Knowles, B. H., and Ellar, D. J., 1986, Characterization and partial purification of a plasma membrane receptor for Bacillus thuringiensis var. kurstaki lepidopteran-specific δ-endotoxin, J.Cell Sci., 83:89.
Linder, R., 1984, Alteration of mammalian membranes by the co-operative and antagonistic actions of bacterial proteins, Biochim.Biophys.Acta, 770:423.
Loridan, C., and Alouf, J. E., 1986, Purification of RNA-core induced stretolysin S, and isolation and haemolytic characteristics of the carrier-free toxin, J.Gen.Microbiol., 132, 307.
Mason, D., and Tschopp, J., 1985, Isolation of a lytic, pore-forming protein (perforin) from catalytic T-lymphocytes, J.Biol.Chem. 260:9069.
Moolten, F., Zajdel, S., and Cooperband, S., 1976, Immunotherapy of experimental animal tumors with antitumor antibodies conjugated to diphtheria toxin or ricin, Ann.N.Y.Acad.Sci., 277:690.
Muller, B., and Muller-Ruchholtz, 1987, Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activation, Leukemia Res. 11:461.
Podack, E. R., Young, J. D.-E., and Cohn, Z. A., 1985, Isolation and biochemical and functional characterization of perforin I from cytolytic T-cell granules, Proc.Natl.Acad., Sci.USA 82:8629.
Smyth, J., and Duncan, J. L., 1978, Thiol-activated (oxygen-labile) cyto-lysins, in: “Bacterial Toxins and Cell Membranes,” J. Jeljaszewiaz, and T. Wadstrom, eds., Academic Press, London pp. 130–183.
Stephen, J., and Pietrowski, R. A., 1986, Bacterial Toxins, 2nd Edition, van Nostrand Reinhold, England.
Thelestam, M., and Mollby, R., 1980, Interaction of streptolysin O from Streptococcus pyogenes and theta-toxin from Clostridium perfringens with human fibroblasts, Infee.Immun. 29:863.
Vogel, C.-W., and Muller-Eberhard, H. J., 1981, Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase, Proc.Natl.Acad.Sci. USA 78:7707.
Vogel, C.-W., Wilkie, S. D., and Morgan, A. C., 1985, In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors, in: “Modern Trends in Human Leukemia IV,” R. Neth, R.C. Gallo, M.F. Greaves, and G. Janka, eds., Springer-Verlag, Berlin, pp. 514–517.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Drobniewski, F.A., Thorpe, P.E., Wallace, P.M., Wawrzynczak, E.J. (1988). The Potential of Membrane-Acting Toxins for Targeted Cancer Therapy. In: Gregoriadis, G., Poste, G. (eds) Targeting of Drugs. NATO ASI Series, vol 155. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5574-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5574-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5576-2
Online ISBN: 978-1-4684-5574-8
eBook Packages: Springer Book Archive